There is an increasing number of stem cell transplants (SCT) that are being performed in US. This, along with an increasing fraction of older and sicker patients being transplanted, makes SCT related renal toxicity a common complication of this life-saving procedure. Particular focus is on the differences in etiology and incidence of renal failure in myeloablative vs. non-myeloablative stem cell transplantation.

Time Required (estimated): 30 minutes
Title: Renal Complications of Stem Cell Transplantation
Author: Sridhar Reddy Allam, MD MPH
Author Type: Fellow
Citation: Nephrology On-Demand 2010
Date Created: 2010
Revisions: None Indicated
Disclaimers: None Indicated
Resource Type: Video
Recommend to a Colleague/Friend


To view the interactive video, click here
To view this video using an iPad or iPhone, see below
To test your knowledge of this topic, click here


Transparent Peer Review
Your reviews are anonymous

[starratingmulti id=”3″]

To learn more about our 6-point transparent peer review system, click here



You must be logged in to post a comment.




Speak your mind

  • Nephrology On-Demand Plus

    Our full-featured iOS app for the iPhone and iPad. NOD + integrates
    1. kidney education,
    2. training, and
    3. recruitment

    into a streamlined and user-friendly interface.


  • Kidney Konnection

    A newsletter that discusses sophisticated topics in Nephrology for physicians in Internal Medicine.
    Click here to access your complimentary subscription